參考文獻/References:
[1] Smith S,Harmanci H,Hutin Y,et al.Global progress on the elimination of viral hepatitis as a major public health threat: An analysis of WHO Member State responses 2017[J].JHEP Rep,2019,1(2): 81-89.
[2] Mullish B H,Kabir M S,Thursz M R,et al.Review article:depression and the use of antidepressants inpatients with chronic liver disease or liver transplantation[J].Aliment Pharmacol Ther,2014,40(8):880-892.
[3] 王貴強,王福生,莊輝,等.慢性乙型肝炎防治指南(2019年版)[J].中華實驗和臨床感染病雜志(電子版),2019,13(6): 441-466.
[4] 賀晶,楊慧霞,段濤,等.妊娠期肝內膽汁淤積癥診療指南(2015)[J].臨床肝膽病雜志,2015,(10)：1575-1578.
[5] Chappell L C,Bell J L,Smith A,et al.Ursodeoxycholic acid versus placebo in women with intrahepatic cholestasis of pregnancy (PITCHES): a randomised controlled trial[J].Lancet,2019,394: 849-860.
[6] 陳成偉,于樂成,茅益民,等.藥物性肝損傷診治指南[J].中華肝臟病雜志,2015,(11)：810-820.
[7] 何燕玲,張明園.精神科評定量表手冊[M].長沙：湖南科學技術出版社,2015: 161.
[8] 陸林,沈漁邨.精神病學[M].6版.北京: 人民衛(wèi)生出版社,2018：399.
[9] 馬辛,李凌江.中國抑郁障礙防治指南[M].2版.北京：中華醫(yī)學電子音像出版社,2015：97.
[10] Ovadia C,Seed P T,Sklavounos A,et al.Association of adverse perinatal outcomes of intrahepatic cholestasis of pregnancy with biochemical markers: results of aggregate and individual patient data meta-analyses[J].Lancet,2019,393: 899-909.
[11] Marku E,Maltese P E,Koni M,et al.Polymorphism of UGT1A1*28 (TA)7 and liver damage in hepatitis B virus-positive patients in Albania[J].Genet Mol Res,2015,14: 5221-5228.
[12] 林麗燕,王碧芬,賴瑾.住院乙型肝炎肝硬化患者睡眠障礙與社會支持的相關性研究[J].護理實踐與研究,2021,18(10):1469-1473.